You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《港股》恆指收升173點 內險及醫藥股領漲 恆瑞醫藥飆逾24%
美歐達成關稅框架協議,美股期貨上升,港股造好。恆指高開70點,其後升幅擴大至279點一度高見25,667點,全日升173點或0.7%,收25,562點;國指升26點或0.3%,收9,177點;恆生科技指數跌13點或0.2%,收5,664點。大市全日成交總額2,502.99億元。 騰訊(00700.HK)、京東(09618.HK)及阿里(09988.HK)相繼發布AI產品及資料,阿里升2.2%報120.6元,騰訊及京東升0.9%及0.5%。商湯(00020.HK)發布新AI模型,股價高開後倒跌,全日跌6.3%。其他科技股方面,中芯(00981.HK)、百度(09888.HK)及快手(01024.HK)升0.3%至0.7%,美團(03690.HK)跌0.5%,網易(09999.HK)及嗶哩嗶哩(09626.HK)跌1.2%及1.4%,丘鈦(01478.HK)及新東方(09901.HK)升3.6%及3.2%,東方甄選(01797.HK)升6.2%。 車股方面,小米(01810.HK)跌1%,吉利(00175.HK)及零跑(09863.HK)跌2%及4.4%,比亞迪(01211.HK)跌1.2%。電池股寧德時代(03750.HK)升6.2%,鋰業股贛鋒鋰業(01772.HK)及天齊鋰業(09696.HK)跌6.7%及6.2%。 內地下調保險產品預定利率上限,保險股造高,國壽(02628.HK)、太保(02601.HK)、中國平安(02318.HK)及中國太平(00966.HK)升3.2%至3.9%,友邦(01299.HK)炒高5%。其他金融股方面,匯控(00005.HK)升0.1%,港交所(00388.HK)升3.1%。 恆瑞醫藥(01276.HK)宣布與葛蘭素史克簽署創新藥授權協議,將獲5億美元首付款,最多潛在總金額約120億美元,股價升24.5%。中生製藥(01177.HK)及康希諾(06185.HK)升7.1%及10.7%,翰森(03692.HK),石藥(01093.HK)及信達生物(01801.HK)升逾5%。康龍化成(03759.HK)升4.9%。 華潤飲料(02460.HK)預告上半年淨利潤減兩至三成,股價挫13.1%。同業農夫山泉(09633.HK)跌2.8%。中免(01880.HK)半年淨利潤倒退21%,股價跌5.5%。同程旅行(00780.HK)跌10.9%。汽車代理中升(00881.HK)跌5.5%。老鋪黃金(06181.HK)預告上半年多賺2.79至2.88倍,股價高開後倒跌,全日跌4.1%。濠賭股澳博(00880.HK)及新濠國際(00200.HK)炒高5.8%及4.9%。航空股東航(00670.HK)、南航(01055.HK)及國航(00753.HK)跌逾3%。 巨星傳奇(06683.HK)折讓19.9%先舊後新配股淨籌3.24億元,股價低開後倒升,全日升2.6%。本地地產股新世界(00017.HK)及九倉置業(01997.HK)升6%及3.7%。光伏股信義玻璃(00868.HK)及協鑫科技(03800.HK)跌4.5%及4.9%,金礦股招金(01818.HK)及山東黃金(01787.HK)跌2.8%及3.2%。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account